Key result
Bronchiolitis obliterans syndrome remains highly prevalent and is the major limitation to long-term survival after lung transplantation, with few effective treatments currently available.
Bronchiolitis obliterans syndrome remains a major limitation to long-term survival after lung transplantation, highlighting the need for better preventive strategies and pharmacological targets.
No takes yet. Share an insight, caveat, or question.
CLAD remains the major barrier to long-term lung transplant survival; leaves open need for targeted pathway-specific interventions in prospective trials.
Derhovanessian et al. (2013) conducted a review in Bronchiolitis Obliterans Syndrome. Bronchiolitis obliterans syndrome remains highly prevalent and is the major limitation to long-term survival after lung transplantation, with few effective treatments currently available.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: